Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Steve Pagliuca Says AI, Pharma, Sports Are Key Investment Focus
PagsGroup Chief Executive Officer Stephen Pagliuca sees a clutch of growing industries, including artificial intelligence and sports, as a key focus for investment over the long term. AI is entering a 10-to-20-year growth phase as it shifts from…
Marksans Pharma to acquire Germany-based ABCnow GmbH
Marksans Pharma Ltd on Wednesday said it will acquire Germany-based pharmaceutical wholesale and distributor ABCnow GmbH for euro 8,92,384 (nearly ₹10 crore). The company has entered into a definitive agreement to acquire 100 per cent of the…
Indian Stock Markets Rebound: Sensex, Nifty Up on FII Inflows, Global Cues
Indian stock markets, including the Sensex and Nifty, staged a significant rebound in early trade on Thursday, recovering from a sharp fall in the previous session, bolstered by foreign institutional investor inflows and strategic buying in…
Natco Pharma to raise stake in Adcock Ingram to 49% with ₹1,400 crore investment
The board of directors of Natco Pharma has approved the acquisition of an additional shareholding in Adcock Ingram Holdings Proprietary Ltd with an investment of up to ₹1400 crore. This acquisition is valued at ₹1,069 crore at the…
Sensex falls 1,700 points as Trump's latest Iran outburst rattles global markets
Indian equity markets saw a sharp sell-off on Wednesday, with the benchmark Sensex and Nifty 50 tumbling as investors reacted to escalating tensions in West Asia. Market sentiments weakened after the US military launched attacks on Iran, claiming…
Boom Times For Autoimmune Disease Therapies
In this week's edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI's healthcare push, Vertex's $10 billion purchase of Crinetics, and more. To get it in your inbox, subscribe here. AbbVie's Skyrizi is on track to…
Is IQVIA Holdings (IQV) Resilient to AI Concerns?
Artisan Partners, an investment management firm, issued its first-quarter 2026 investor letter for the 'Artisan Mid Cap Value Fund'. A copy of this letter is available for download here. In Q1 2026, the portfolio underperformed the benchmark…
Is It Too Late to Buy Eli Lilly?
Eli Lilly (LLY 1.27%) stock has been winning big when it comes to earnings and stock performance in recent years. And this has a lot to do with the company's leadership in a type of drug that's taken the world by storm: GLP-1 drugs for weight loss.
Rush for GLP-1 weight-loss & diabetes drugs plateaus, says industry-tracker
After the race to launch generic semaglutide for weightloss and diabetes, the anti-diabetes market has stabilized, even as innovator drugs hold their own in this category, reveals Pharmatrack's data for June. Innovator companies Novo Nordisk with…
TurtleTree, Novonesis strike partnership to scale up precision-fermented lactoferrin
Biotech startup TurtleTree and biosolutions giant Novonesis have struck an agreement to scale the former's precision fermentation platform, starting with its lactoferrin product. The partnership includes a minority investment into TurtleTree on the…
Welltower: Continued Property Acquisitions Support The Investment Case (NYSE:WELL)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Nifty rebounds 137 points at open after worst day in three months; IT stocks drag as TCS results due
Benchmarks opened higher on Thursday, July 9, 2026, attempting a recovery after suffering their steepest single-session fall in over three months in the previous session. The BSE Sensex, which had closed at ₹76,503.60 on Wednesday, opened at…
VYMI vs. VIGI: Which International Dividend ETF Is Better?
Is America still the best place in the world for Americans to invest? Recent research from Vanguard suggests that international stocks might offer stronger opportunities in the next few years. The company's 2026 economic and market outlook said…
Dr Reddy's delays semaglutide supply due to active ingredient issue
July 9 Dr Reddy's Laboratories said on Thursday that it is delaying commercial supplies of semaglutide due to an issue related to the active pharmaceutical ingredient used in the drug, sending its shares down.
Stock Market Highlights, July 8: Sensex, Nifty sink over 2% after Trump's Iran remarks trigger oil price fears
Sensex Today, Nifty 50 | Stock Market Highlights - Indian equity markets suffered a sharp sell-off in the final hour of trading after US President Donald Trump signalled that negotiations with Iran were effectively over and confirmed renewed US…
Receive a Daily briefing on Pharma Industry News
Get Started